Chemical Compound
DAUNORUBICIN HYDROCHLORIDE
CAS Registry Number
23541-50-6
Primary Record
DAUNORUBICIN HYDROCHLORIDE
- In stock
- 3,165 g
- Purity
- 98.6 %
- CAS
- 23541-50-6
Compound Identifiers & Properties
- CAS
- 23541-50-6
- PubChem CID
- 62770
- SMILES
- C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N)O.Cl
- Canonical SMILES
- COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(C)=O)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1.Cl
Names & Synonyms
- DAUNORUBICIN HYDROCHLORIDE
- DAUNORUBICIN HCL
- Cerubidine
- 23541-50-6
- Daunoblastin
- Daunoblastina
- Ondena
- daunorubicin
- Rubomycin
- Daunomycin hydrochloride
- Daunoblastine
- Rubidomycin hydrochloride
- Daunomycin
- Rubilem
- RP 13057 hydrochloride
- DaunoXome
- Daunomycin chlorohydrate
- Daunomycin HCL
- Daunorubicin.HCl
- Daunomycin, HCl
- Daunomycin, hydrochloride
- Cerubidine (TN)
- daunorubicinol hydrochloride
- RP-13057 Hydrochloride
- daunorubcin hydrochloride
- CCRIS 915
- RefChem:54934
- AC1L1XQY
- Daunorubicin (Hydrochloride)
- Daunorubicin (as hydrochloride)
- UD984I04LZ
- UNII-UD984I04LZ
- FI 6339 HYDROCHLORIDE
- FI-6339 HYDROCHLORIDE
- DTXSID0033382
- MFCD04974507
- Cloridrato de Daunorubicina
- FI 6339 [as the base]
- Hydrochloride, Daunorubicin
- Daunorubicini Hydrochloridum
- SCHEMBL4444
- CHEMBL1563
- Daunomycin, monohydrochloride
- DTXCID8013382
- NDC 0082-4155
- C27H30ClNO10
- MLS000069508
- MLS001336042
- MLS002222263
- C27H29NO10.ClH
- C27H29NO10.HCl
- Daunorubicin hydrochloride CRS
- EINECS 245-723-4
- GUGHGUXZJWAIAS-QQYBVWGSSA-N
- NSC-82151
- orb1308388
- Hydroxydaunorubicin hydrochloride
- RP 13057 [as the base]
- SCHEMBL29354055
- SCHEMBL29462666
- CHEBI:31456
- Daunorubicin hydrochloride =98%
- AOB5597
- C27H29NO10
- GLXC-06680
- Daunorubicin HCl (Daunomycin HCl)
- Daunorubicin hydrochloride [USAN:JAN]
- Daunorubicin hydrochloride(BICINS)
- CID62770
- EX-A2649
- NSC82151
- NSC83142
- AI3-44887
- C27-H29-N-O10.Cl-H
- Tox21_201159
- BBF-03858
- CCG-39942
- EBC-11147
- HB4376
- HY-13062R
- MSK001345A-100M
- NSC 82151
- s3035
- Daunomycin; RP 13057; Rubidomycin
- Daunorubicin HCl - Bio-X trade mark
- AKOS015920259
- METHYL3-METHYL-4-NITROBENZOATE
- RP 13057 [AS THE BASE)
- ACN-036866
- AN-5825
- CS-1271
- Daunorubicin hydrochloride (JP18/USP)
- DAUNORUBICIN HYDROCHLORIDE [MI]
- Daunorubicin hydrochloride [USAN:USP:JAN]
- DAUNORUBICIN HYDROCHLORIDE 20MG
- Doxorubicin EP Impurity A (HCl Salt)
- KS-5149
- MD11679
- MSK001345A-1000M
- NDC-0082-4155
- Daunorubicin (hydrochloride) (Standard)
- DAUNORUBICIN HYDROCHLORIDE [JAN]
- DAUNORUBICIN HYDROCHLORIDE 100MG
- DAUNORUBICIN HYDROCHLORIDE [USAN]
- NCGC00024246-03
- NCGC00258711-01
- BD164356
- BR-73029
- DAUNORUBICIN HYDROCHLORIDE [MART.]
- DAUNORUBICIN HYDROCHLORIDE [VANDF]
- HY-13062
- LS-59205
- Q716
- SMR000058559
- SMR000768722
- SY058973
- DAUNORUBICIN HYDROCHLORIDE [USP-RS]
- DAUNORUBICIN HYDROCHLORIDE [WHO-DD]
- (8S-cis)-8-Acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione hydrochloride
- 23541-50-6 (HCl)
- AB0069872
- CAS-23541-50-6
- Daunorubicin hydrochloride, >=90% (HPLC)
- ST2419213
- B2285
- FT-0777616
- NS00084572
- ST51042193
- A10194
- D01264
- DAUNORUBICIN HYDROCHLORIDE [ORANGE BOOK]
- S-4916
- WP900 hydrochloride, >=95% (HPLC), solid
- (8S,10S)-8-acetyl-10-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione hydrochloride
- DAUNORUBICIN HYDROCHLORIDE [EP MONOGRAPH]
- DAUNORUBICIN HYDROCHLORIDE [USP IMPURITY]
- 541D506
- A816764
- DAUNORUBICIN HYDROCHLORIDE [USP MONOGRAPH]
- SR-01000000033
- SR-05000001600
- SR-01000000033-6
- SR-05000001600-3
- Q27291034
- Daunorubicin hydrochloride, meets USP testing specifications
- Daunorubicine hydrochloride Solution in Methanol, 1000ug/mL
- Daunorubicine hydrochloride Solution in Methanol, 100ug/mL
- (1S,3S)-3-Acetyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1-naphthacenyl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside hydrochloride
- 5,12-Naphthacenedione, 8-acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S-cis)-, hydrochloride
- Daunorubicin Hydrochloride; RP 13057 Hydrochloride; Daunomycin
- (8S,10S)-8-Acetyl-10-[[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy]-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione Hydrochloride
- 20830-81-3
- 5,12-Naphthacenedione, 8-acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl))oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S-cis)-, hydrochloride
- 5,12-Naphthacenedione, 8-acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trhydroxy-1-methoxy-, hydrochloride, (8S,10S)-
- 5,12-Naphthacenedione, 8-acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, hydrochloride, (8S,10S)-
- Daunorubicin hydrochloride, European Pharmacopoeia (EP) Reference Standard
- N',N'-dimethyl-N-(2-nitroacridin-9-yl)butane-1,4-diamine,dihydrochloride
- Daunorubicin hydrochloride, 97%, an inhibits both DNA and RNA synthesis - 25MG 25mg
- Daunorubicin hydrochloride, United States Pharmacopeia (USP) Reference Standard
- (1S,3S)-3-ACETYL-1,2,3,4,6,11-HEXAHYDRO-3,5,12-TRIHYDROXY-10-METHOXY-6,11-DIOXO-1-NAPHTHACENYL 3-AMINO-2,3,6-TRIDEOXY-.ALPHA.-L-LYXO-HEXOPYRANOSIDE HYDROCHLORIDE
- (1S,3S)-3-Acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside--hydrogen chloride (1/1)
- (2S,4S)-2-Acetyl-4-(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyloxy)-2,5,12-trihydroxy-7-methoxy-1,2,3,4-tetrahydrotetracene-6,11-dione monohydrochloride
- (7S,9S)-9-acetyl-7-[(2R,4S,5R,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione,hydrochloride
- (7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione hydrochloride
- (7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride
- (7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione hydrochloride
- (7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride
- (8S,10S)-8-acetyl-10-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dionehydrochloride
- (8S,10S)-8-acetyl-10-{[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy}-6,8,11-trihydroxy-1-methoxy-5,7,8,9,10,12-hexahydrotetracene-5,12-dione hydrochloride
- 23541-82-4
- 245-723-4
- 5,12-Naftacenediona, 8-acetil-10 [(3-amino-2,3,6-trideoxi-alfa-L-lixo-hexopiranosil)] oxi-7,8,9,10-tetrahidro-6,8,11-trihidroxi-1-metoxi-, clorhidrato (1:1), (8S, 10S)-
- 5,12-NAPHTHACENEDIONE, 8-ACETYL-10-((3-AMINO-2,3,6-TRIDEOXY-.ALPHA.-L-LYXO-HEXOPYRANOSYL))OXY)-7,8,9,10-TETRAHYDRO-6,8,11-TRIHYDROXY-1-METHOXY-, (8S-CIS)-, HYDROCHLORIDE
- 5,12-Naphthacenedione, 8-acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, hydrochloride, (8S-cis)-
- 5,12-Naphthacenedione, 8-acetyl-10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, hydrochloride, (8S,10S)-
- 5,12-Naphthacenedione, 8-acetyl-10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, hydrochloride, (8S-cis)-
- 5,12-Naphthacenedione,8-acetyl-10-[(3-aMino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-Methoxy-,hydrChemicalbookochloride(1:1),(8S,10S)-
- 56390-08-0
- Epirubicin Hydrochloride Imp. D (EP); Epirubicin Imp. D (EP); Daunorubicin hydrochloride; (8S,10S)-8-Acetyl-10-[(3-amino-2,3,6-trideoxy-a-l-lyxo-hexopyranosyl)oxy]-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione hydrochloride; Doxorubicin Hydrochloride Impurity A as Hydrochloride; Epirubicin Hydrochloride Impurity D as Hydrochloride; Doxorubicin Impurity A as Hydrochloride; Epirubicin Impurity D as Hydrochloride
- L-lyxo-Hexopyranoside, 3beta-acetyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-10-metldioxo-1a-naphthacenyl 3-amino-2,3,6-trideoxy-,alpha-,hydrochloride